Timothy Clifton
Greenville, NCNPI 1043666514
Payments from drug & device makers
$2,370in general payments, 2019–2025
Across 128 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$628
- Ironshore Pharmaceuticals Inc.$355
- Tris Pharma Inc$255
- Merck$172
- Sanofi-aventis U.S. LLC$145
- Sanofi Pasteur Inc.$145
- plus $670 from 16 others
What the payments were for
- Food & beverage$2,370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 30 | $628 |
| Ironshore Pharmaceuticals Inc. | 17 | $355 |
| Tris Pharma Inc | 16 | $255 |
| Merck | 12 | $172 |
| Sanofi-aventis U.S. LLC | 5 | $145 |
| Sanofi Pasteur Inc. | 7 | $145 |
| Adlon Therapeutics L.p. | 9 | $134 |
| GSK | 6 | $104 |
| Pfizer | 4 | $64 |
| Neos Therapeutics, LP | 4 | $56 |
| Seqirus USA Inc | 2 | $51 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 3 | $45 |
| Biogen | 2 | $29 |
| Photonicare Inc | 1 | $22 |
| Sobi, Inc | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.